Fig. 3: Progression-free survival and overall survival in NET G3.

Overall survival (OS) (a) and progression-free survival (PFS) (b) in NET G3 with Ki-67 < 55% according to first-line chemotherapy regimen and OS in NET G3 according to performance status (c) and alkaline phosphatase (ALP) level (d).